The blood-brain barrier presents a major obstacle to brain drug delivery. We have developed several different enabling platforms for the identification of antibodies against blood-brain barrier resident receptors that can be used to ferry drug cargo into the brain. Here we will describe our recent efforts to identify and deploy these antibodies.